Bone & Musculoskeletal Disease

BCH 130 — Advanced Human Biochemistry · Dr. Radi

build Jul 18 · 08:24 · CC BY-NC-SA 4.0 · owned figures (RDKit / matplotlib)
Dr. Radi

By the end of this unit, you can…

  • Explain bone remodeling (osteoblast/osteoclast coupling, RANKL/RANK/OPG, Wnt/sclerostin) as the framework for osteoporosis.
  • Connect estrogen deficiency, aging, and glucocorticoid excess to net bone loss, and interpret DXA/T-score and bone-turnover markers.
  • Explain osteoporosis pharmacology by target
  • Describe sarcopenia and the muscle-bone unit — anabolic resistance, myostatin, and the biochemistry of age-related muscle loss.
Dr. Radi

Today's route 🗺️

  1. Osteoporosis — How Bone Is Lost
  2. Osteoporosis Drugs & Sarcopenia
Dr. Radi

1 · Osteoporosis — How Bone Is Lost

"Bone looks like dead scaffolding, but it's the most alive tissue you own — torn down and rebuilt your whole life. Osteoporosis is what happens when the tearing-down team quietly out-works the rebuilding crew. Let's meet the two cells, the molecular dials that referee them, and the three forces that tip the fight toward loss."

Dr. Radi

Bone is a construction site

Here's the surprise: your skeleton is rebuilt constantly. Bone-eating osteoclasts dig a pit and release the growth factors stored in the matrix; those factors recruit osteoblasts to fill the pit back in. That's coupling — resorption and formation chained together. When the two crews stay balanced, bone mass holds steady. Osteoporosis is a coupling that has quietly gone lopsided.

Dr. Radi

The two dials the osteoblast runs

The osteoblast is the foreman, and it works two dials. On the resorption side: it makes RANKL, which docks on RANK to wake up osteoclasts — and it makes OPG, a decoy receptor that mops RANKL up (OPG ⊣ RANKL). On the formation side: Wnt tells the osteoblast to build, and sclerostin is the brake on Wnt (sclerostin ⊣ Wnt). Bone loss = too much RANKL, or too much sclerostin.

Dr. Radi

Three ways the balance tips

Now the villains. Estrogen deficiency (menopause) is the big one — estrogen normally restrains RANKL, so its loss unleashes osteoclasts and lets them live longer. Aging dulls the osteoblasts and raises sclerostin. Glucocorticoid excess — steroids — is brutal on both dials: it kills osteoblasts, pushes RANKL up, and drops OPG. Each one lets the pit outpace the patch.

Dr. Radi

Reading the bone

We measure it two ways. DXA gives a T-score — your density against a healthy young adult, in standard deviations. Normal is above −1; osteopenia sits between −1 and −2.5; osteoporosis is −2.5 or below. DXA tells you the amount. Bone-turnover markers add the rate: CTX tracks resorption, P1NP tracks formation — a fast, cheap readout of whether treatment is working.

Dr. Radi

2 · Osteoporosis Drugs & Sarcopenia

"Here's the payoff of learning the remodeling dials: every osteoporosis drug grabs one of them. Some slam the brakes on resorption, others floor the accelerator on formation — and once you know the target, the drug name explains itself. Then we turn to muscle, because bone never ages alone: its lifelong partner is wasting right beside it."

Dr. Radi

Antiresorptives: shut the osteoclast down

The first family just stops the tearing-down. Bisphosphonates are swallowed into the osteoclast and block farnesyl-PP synthase in the mevalonate pathway — no prenylation, so the cell can't work and dies. Denosumab is an antibody that blocks RANKL — it's basically OPG in a syringe. SERMs (raloxifene) and estrogen lower RANKL too. Different doors, same room: less resorption.

Dr. Radi

Anabolics: tell the osteoblast to build

The second family adds new bone. Teriparatide is PTH given as a daily pulse — and here's the trick: intermittent PTH is anabolic, waking osteoblasts, even though chronic high PTH would strip bone. Romosozumab is an antibody against sclerostin — block the blocker, and Wnt is unleashed to build (it trims resorption at the same time). These are the drugs that grow a skeleton back.

Dr. Radi

Sarcopenia: the muscle wastes too

Bone doesn't age alone. Sarcopenia is the age-related loss of muscle mass and strength, and it runs on the same imbalance — synthesis falling behind breakdown. Two culprits: anabolic resistance, where the same protein or exercise triggers a weaker build-up response, and myostatin, muscle's built-in growth brake, which climbs with age and inactivity. Synthesis can't keep up, and muscle quietly melts away.

Dr. Radi

The muscle–bone unit

Why do they fall together? Because they're coupled, just like the two bone cells. Muscle pulls on bone, and that mechanical loading suppresses sclerostin — so a working muscle literally builds the bone it's anchored to; the two also swap myokine and osteokine signals. Then the same aging decline — falling estrogen, androgen, and GH–IGF-1, plus inactivity — starves both. Treat the unit, not just the scan.

Dr. Radi

Can you…?

  • ☐ explain bone remodeling (osteoblast/osteoclast coupling, RANKL/RANK/OPG, Wnt/sclerostin) as the framework for osteoporosis.?
  • ☐ connect estrogen deficiency, aging, and glucocorticoid excess to net bone loss, and interpret DXA/T-score and bone-turnover markers.?
  • ☐ explain osteoporosis pharmacology by target?
  • ☐ describe sarcopenia and the muscle-bone unit — anabolic resistance, myostatin, and the biochemistry of age-related muscle loss.?

If any box stays empty, the practice site has a drill for it. 🧪

Dr. Radi